Eric Easom, Chief Executive Officer at AN2 Therapeutics, Inc. (ANTX), sold 4,232 shares at $15.39 ($65K) on 2022-10-31, disclosed to the SEC on 2022-11-02.
Scheduled sale ($65k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.39 | 2,688 | $41K | 64.0% |
| 2 | $15.07 | 1,544 | $23K | 36.0% |
| Total | $15.27 avg | 4,232 | $65K | 100% |
| Filing → |
| ANTX | SELL | 2024-01-04 | $112K | — | Filing → |
| ANTX | BUY | 2023-05-15 | $54K | — | Filing → |
| ANTX | SELL | 2022-11-14 | $136K | — | Filing → |